Photo by amir_bnl from unsplash
Abstract Topical imiquimod is used for a variety of common dermatologic lesions, including melanoma in-situ. As an immunomodulator, it is relatively well tolerated with minimal side effects, including scaling, erythema,… Click to show full abstract
Abstract Topical imiquimod is used for a variety of common dermatologic lesions, including melanoma in-situ. As an immunomodulator, it is relatively well tolerated with minimal side effects, including scaling, erythema, and edema. Here we present a rare systemic adverse effect, where our patient experienced debilitating severe fatigue when applying imiquimod to a single lesion. Clinicians should be mindful of this side effect and counsel patients appropriately.
Keywords:
imiquimod induced;
induced fatigue;
imiquimod;
topical imiquimod;
case topical
Journal Title: Journal of Dermatological Treatment
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Dermatological Treatment
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!